Abstract
Objective: The role of the human fibroblast growth factor receptor (FGFR) gene family in current prenatal diagnosis and management of craniosynostosis syndromes and skeletal dysplasias is discussed. Method: We present the antenatal ultrasound findings, diagnosis, and management of 2 cases of Apert syndrome before and after molecular prenatal diagnosis was available. Results and Conclusion: Discovery of mutations in FGFR genes now allows the definitive antenatal diagnosis of Apert syndrome, other craniosynostosis syndromes, and skeletal dysplasias.
Original language | English |
---|---|
Pages (from-to) | 127-130 |
Number of pages | 4 |
Journal | Fetal Diagnosis and Therapy |
Volume | 19 |
Issue number | 2 |
DOIs | |
State | Published - 2004 |
Keywords
- Apert syndrome
- Craniosynostosis
- Fibroblast growth factor receptor-2
- Syndactyly
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Embryology
- Radiology Nuclear Medicine and imaging
- Obstetrics and Gynecology